Vascular tumors and vascular malformations: Evidence for an association

Journal of the American Academy of Dermatology

Volumn 42, Issue 2 I, 2000, Pages 275-279

  Garzon, Maria C ^a   Enjolras, Odile ^b   Frieden, Ilona J ^c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Paris Descartes University   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONGENITAL BLOOD VESSEL MALFORMATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HISTOPATHOLOGY; PRIORITY JOURNAL; VASCULAR TUMOR;

EID: 0033914227     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(00)90138-5     Document Type: Article

References (31)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-20.
2. Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J, Ezekowitz AB. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:2357-64.
3. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol 1998;13:375-422.
4. Grevelink SV, Mulliken JB. Vascular anomalies. In: Freedberg IA, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, et al, editors. Fitzpatrick's Dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1999. p. 1175-94.
5. Blei F, Walter J, Orlow SJ, Marchuk DA. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 1998;134:718-22.
6. Beers BB, Rustad OJ, Vance JC. Pyogenic granuloma following laser treatment of a port-wine stain. Cutis 1988;41:266-8.
7. Elder D, editor. Lever's Histopathology of the skin. 8th ed. Philadelphia: Lippincott-Raven; 1997.
8. Swerlick R, Cooper P. Pyogenic granuloma (lobular capillary hemangioma) within port-wine stains. J Am Acad Dermatol 1983;8:627-30.
9. Holloway KB, Ramos-Caro FA, Brownlee RE, Flowers FP. Giant proliferative hemangiomas arising in a port-wine stain. J Am Acad Dermatol 1994;31:675-6.
10. Mulliken JB, Young AE. Vascular birthmarks: hemangiomas and malformations. Philadelphia: WB Saunders; 1988.
11. Albright AL, Gartner C, Weiner ES. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics 1989; 83:977-80.
12. Goldberg NS, Hebert AE, Esterly NB. Sacral hemangiomas and multiple congenital abnormalities. Arch Dermatol 1986;122: 684-7.
13. Hersh JH, Waterfill D, Rutledge J, Harrod MJE, O'Sheal SF, Verdi G, et al. Sternal malformation/vascular dysplasia association. Am J Med Genet 1985;21:177-86.
14. Reese V, Frieden IJ, Paller AS, Esterly NB, Ferriero D, Levy ML, et al. Association of facial hemangiomas with Dandy-Walker and other posterior fossa malformations. J Pediatr 1993;122:379-84.
15. Boulinguez S, Teillac-Hamel D, Bedane C, Bennaceur S, De Prost Y. Cervicofacial hemangioma and a minor sternal malformation: Inclusion in PHACES syndrome? Pediatr Dermatol 1998;15: 119-21.
16. Pascual-Castroviejo I. Vascular and nonvascular intracranial malformations associated with external capillary hemangiomas. Neuroradiology 1978;16:82-4.
17. Frieden IJ, Reese V, Cohen D. PHACE syndrome: the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996;132:307-11.
18. Burrows PE, Robertson RL, Mulliken JB, Beardsley DS, Chaloupka JC, Ezekowitz RAB, et al. Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology 1988;207:601-7.
19. Perkins P, Weiss SW. Spindle cell hemangioendothelioma: an analysis of 78 cases with reassessment of its pathogenesis and biologic behavior. Am J Surg Pathol 1996;20:1196-1204.
20. Enjolras O, Wassef M, Merland JJ. Syndrome de Maffucci: Une fausse malformation veinuse? Ann Dermatol Venereol 1998; 125:512-5.
21. Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood. Am J Surg Pathol 1993; 17:321-8.
22. Enjolras O, Wassef M, Mazoyer E, Frieden IJ, Rieu PN, Drouet L, et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr 1997;130:631-40.
23. Sarkar M, Mulliken JB, Kozakewich HPW, Robertson RL, Burrows PE. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997;100:1377-86.
24. Kerhoas Nicolas CK, Le Bidaut M, Dosquet C, Enjolras O, Stalder JF. Syndrome de Kasabach-Merritt d'un membre associe a une osteolyse ou signe de Gorham. Ann Dermatol Venereol 1997; 124:852-4.
25. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-63.
26. Beck L, D'Amore PA. Vascular development: cellular and molecular regulation. FASEB J 1997;11:365-73.
27. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-4.
28. Folkman J, D'Amore PA. Blood vessel formation: What is its molecular basis? Cell 1996;87:1153-5.
29. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994;8:345-51.
30. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996;13:189-95.
31. Vikkula M, Boon LM, Carraway KL, Calvert JT, Diamonti AJ, Goumnerov B, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996;87:1181-90.